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Abstract 
Background: Hepatic Actinomycosis (HA) is one of the infections that causes disorders in patients when diagnosed 
untimely and inappropriately.
Methods: Case reports on HA in patients published between 2000 and April 2020 were gathered by carrying out a 
structured search through PubMed/Medline.
Results: Through a survey of the Medline database, 130 studies were identified and then, 64 cases with HA were 
included in the final analysis. Asia had the largest share of cases with 37.5% (24 reports), followed by Europe and the 
Americas. Affected patients were predominantly males (64%) and the overall mortality rate was 1% with only one 
male patient in his 50 s dying. Nearly all patients (92%) were immunocompetent. However, in four patients, the use 
of immunosuppressive medication led to depression of the immune system. Most of the patients (80%) experienced 
complications. In terms of the complications, the most frequent ones were previous history of abdominal surgery 
(32%) and foreign bodies in the abdominopelvic region (20%). Actinomyces israelii was the most common pathogen 
isolated from patients. Abdominal pain (66%), fever (62%), weight loss (48%), night sweat, malaise, and anorexia (14%) 
over about 3.1 months were the most frequently reported clinical symptoms. Extension to one or more surrounding 
organs was evident in 18 patients (28%). Histopathologic examination confirmed infection in 67% of the patients 
and samples obtained from liver puncture biopsy (32%) were most frequently used in diagnosis. Surgery or puncture 
drainage + anti-infection was the most common method to treat patients and penicillin, Amoxicillin, Doxycycline, and 
ampicillin were the most frequently used drugs to control infection.
Conclusion: HA should be considered in patients with a subacute or chronic inflammatory process of the liver. With 
accurate and timely diagnosis of infection, extensive surgery can be prevented.
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Introduction
Actinomyces spp. are opportunistic gram-positive, 
anaerobic, or facultatively anaerobic bacteria that usu-
ally colonize the upper respiratory tract or the gastro-
intestinal and female genital tract and typically infect 
males between 20 and 60  years old [1, 2]. Granuloma-
tous inflammation, abscesses, contiguous spread, and 
formation of sinus tract fistulae are the distinguishing 
characteristics of chronic actinomycosis. This type of 
infection has been addressed in the research for more 
than 150  years with the most common agent being 
Actinomyces israelii [2–4]. Actinomyces have low patho-
genicity and their infection has subacute manifestation. 
However, polymicrobial infections frequently occur in 
patients being involved with actinomycosis, promoting 
pathogenicity of these bacteria [3, 5]. Fortunately, drug 
resistance is not an issue in the treatment procedure and 
beta-lactams, particularly penicillin G or Amoxicillin, are 
extremely influential in Actinomyces spp., making them 
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an ideal choice for treatment [6, 7]. Treatment of actino-
mycosis should focus on antibiotic therapy and surgery 
alone does not seem to be a suitable method for treat-
ment, although in refractory cases, surgery can be a sup-
porting therapy [3, 8].
While any site in body can be involved with actinomy-
cosis, cervicofacial infection is the most common one. 
Other parts of the body prone to be infected with Actino-
myces spp. are thorax, abdomen, pelvis, and the central 
nervous system [3, 4]. Abdominal infection occurs in 
20% of cases and appendix and the ileocecal region are 
generally affected [9]. Hepatic involvement is usually 
uncommon and occurs after other intra-abdominal sites 
of infection. Hepatic Actinomycosis (HA) occurs in only 
15% of the abdominal infections and, in total, makes up 
5% of all actinomycosis cases [5, 10]. Diagnosis of HA is 
often challenging, because infection diagnosis is depend-
ent on clinical manifestations and findings from imaging. 
Thus, it can be simply misdiagnosed as a primary liver 
cancer when it is in the form of a solitary tumor or meta-
static with multiple imaging features [8, 11, 12]. In this 
regard, actinomycosis often mimics malignancy, tubercu-
losis, or nocardiosis due to its progressive and constant 
expansion that may form a cold abscess [7, 13]. Therefore, 
diagnosing HA in patients is usually challenging and in 
some cases, this leads to extensive surgery and perma-
nent damage. The present research is the first systematic 
review aimed at studying the reported HA cases in differ-
ent patients.
Method
Literature search and inclusion criteria
In the present research, a Medline (via PubMed) search 
was carried out between the years 2000 and 2020. The 
keywords for search were taken from the National 
Library of Medicine’s Medical Subject Heading (MeSH) 
terms, titles, or abstracts through Boolean operators 
(and/or) including “Actinomyces” or “Actinomycosis” 
or “Actinomycotic”, and “Liver” or “Hepatic.” It should 
be noted that only studies in English language were 
included. Of the total 130 hits, 64 were included based 
on the inclusion criteria given in Fig. 1. The protocol for 
review employed in the present research was adopted 
from our recent article and a study conducted by Hickey 
et al. [14, 15].
Inclusion criteria
The systematic review was carried out by the given inclu-
sion criteria: individual case reports on HA in different 
patients, full texts or abstracts of studies published in 
English, and online studies published on Medline (via 
PubMed) from 2000 up to April, 2020.
Exclusion criteria
The exclusion criteria were non-human studies, review 
articles, guidelines, systematic reviews or meta-analyses, 
actinomycosis without propagation of infection into the 
liver, and incomplete reported data (Fig. 1).
Study selection and data extraction
Two researchers (AS and ZC) screened the articles and 
when discrepancy was observed, they skimmed the paper 
or conference abstract as a case to be reviewed by both 
in collaboration. For each article, the following features 
were extracted and recorded through Excel software 
(Microsoft, Redmond, WA, USA): country, publication 
year, sex, age, causative pathogen, medical history and co-
morbidities, clinical presentation, antibiotics treatment, 
surgery and drainage, diagnostic method, and outcome. 
The references of the articles were comprehensively sur-
veyed to make sure that there were no additional cases 
remaining unidentified from the primary search.
Quality assessment
The critical checklist for appraisal put forward by the 
Joanna Briggs Institute (JBI) was adopted in order to 
assess the quality of studies [16].
Results
Epidemiology
In a survey of the Medline database, 130 cases were 
identified and then, 64 patients with HA were included 
in the final analysis based on the study criteria (Fig.  1). 
These individual cases were published from Bahrain, 
India, France, Italy and Portugal (one each), Canada, Ger-
many, Greece, Romania, Spain, and Serbia (two each), 
the United Kingdom (three reports), Japan (four reports), 
China (five reports), Taiwan and Turkey (six each), Korea 
(seven reports) and finally the USA (16 reports). Accord-
ingly, Asia had the largest share of cases with 37.5% (24 
reports) followed by Europe and the Americas with 34% 
(22 reports) and 28% (18 reports), respectively. No case 
from the continents of Australia and Africa was detected. 
According to the findings of the present study, the overall 
mortality rate was 1% with only one male patient in his 
50 s dying due to thoraco-pulmonary and HA condition 
that rapidly deteriorated and killed him before starting 
treatment. Our results also showed that only 36% of the 
patients were female and the other 64% were male. The 
mean age of patients was 51.6 years (ranging between 5 
and 84) and 55% of the patients were 50 years of age or 
older (Table 1).
Primary or isolated HA (when a primary focus was not 
found) was reported in 61% of the patients, while in 20 
(31%) and 4 (6%) patients, abdominopelvic actinomycosis 
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with liver dissemination and disseminated infection were 
reported, respectively. Also, in one patient, actinomyco-
sis of lungs directly invaded the liver parenchyma with 
IgG4-related hepatopathy through the diaphragm. Nearly 
all patients (92%) were immunocompetent; however, in 
four patients, the use of immunosuppressive medica-
tion prednisolone, plaquinil, prednisone, and tacrolimus 
led to depression of the immune system. In one patient, 
immunodepression by varicella was reported as the most 
likely reason for the acute onset of symptoms. On the 
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Fig. 1 Flow chart of publication selection and their inclusion in the systematic review
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Table 1 Clinical, diagnosis, epidemiological and therapeutic features of patients with hepatic actinomycosis from individual cases
Country, year of 
publication and 
references
Sex/age Species Treatment Surgery or puncture 
drainage
Diagnosis
Bahrain, 2020 [17] 49/f NR Ampicillin discontinued 
due to sepsis, Doxycy-
cline for 6 month
Thoracentesis and inser-
tion of a chest drain
HE
Canada, 2001 [18] 50/m NR Penicillin NR HE




China, 2004 [20] 64/m NR Amoxicillin/clavulanic acid 
for 6 months
Left lateral segmentec-
tomy and distal gastrec-
tomy were performed
HE
China, 2011 [21] 47/F A. israelii Ampicillin for 4 weeks, fol-
lowed by oral Amoxicillin 
for 2 months
Lobectomy of the left liver 
lobe, A right oophorec-
tomy
HE
China, 2013 [22] 67/M NR Penicillin G and oral peni-
cillin for six month
Left lateral hepatectomy 
and distal gastrectomy
HE
China, 2014 [12] 55/M NR Penicillin Left lobe resection HE
China, 2016 [23] 38/M NR Cefoperazone for 7 days 
after the surgery
Left lobectomy of the liver HE
France, 2013 [24] 34/M NR Ampicillin, Penicillin G Appendectomy HE
Germany, 2009 [25] 71/f NR Amoxicillin, imipenem/
cilastatin for Klebsiella 
pneumonia
NR HE
Germany,2001 [26] 57/m NR Penicillin G then Clindamy-
cin for six month
NR HE
Greece, 2004 [27] 53/M NR Ciprofloxacin for 6 weeks A right posterior segmen-
tectomy of the liver was 
performed
HE
Greece, 2010 [28] 70/M NR Amoxicillin-sulbactam, 
amoxicillin
NR HE
India, 2005 [29] 35/m NR Penicillin G, ampicillin for 
5 months
Ultrasound-guided percu-
taneous aspiration of the 
liver abscess
Culture
Italy, 2005 [30] 31/M NR Piperacillin Surgical resection of the 
IV_/VII hepatic segments
HE with a positive culture
Japan, 2011 [31] 74/F A. israelii Ampicillin, Amoxicillin for 
6 month
Aspiration drainage and 
placed an indwelling 
catheter immediately
PCR and culture
Japan, 2012 [9] 60/M NR Sulbactam/ampicillin for 





Japan, 2014 [32] 80/M NR Ampicillin/sulbactam, 
erythromycin, Ampicillin/
sulbactam for two years
A drainage tube was 
inserted into the right 
thoracic space
HE












Korea, 2012 [35] 72/M NR Penicillin for two month Percutaneous drainage for 
2 weeks
HE
Korea, 2012 [36] 41/f NR Ampicillin, amoxicil-
lin treatment for four 
months
A right salpingo-oopho-
rectomy with left ovarian 
excision and IUD removal 
was carried out
HE
Korea, 2012 [37] 67/m A. cardiffensis Ceftriaxone, Amoxicillin for 
6 months
NR Culture, PCR
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Table 1 (continued)
Country, year of 
publication and 
references
Sex/age Species Treatment Surgery or puncture 
drainage
Diagnosis
Korea, 2013 [8] 57/M NR Penicillin G, ceftriaxone, 
Amoxicillin for 11 weeks
Exploratory laparotomy HE
Korea, 2018 [38] 55/F NR Penicillin for 6 months Bilateral salpingo-oopho-




Korea, 2018 [39] 67/M NR NR Lobectomy of the liver HE
Portugal, 2014 [4] 38/M NR Doxycycline for three 
months
Left hepatectomy 
extended to segments V 
and VIII
HE
Romania, 2012 [40] 72/f NR Ampicillin for two months, 
then Doxycycline for 
139 days
Surgical drainage HE
Romania, 2013 [41] 54/m NR Broad-spectrum antibiotics 
and antimycotics
Laparoscopy and biopsy HE
Serbia, 2009 [42] 50/F NR Benzylpenicillin for 6 weeks 
and oral Amoxycillin for 
6 months
Affected liver segments 
were resected
HE
Serbia, 2018 [43] 50/F NR Amoxicillin during three 
months




Spain, 2011 [44] 20/m A. israelii Amoxicillin–clavulanate for 
two month
CT-guided pericardial 
drainage and A left-
sided thoracocentesis, 
Pericardial and hepatic 
drainages
Culture and PCR
Spain, 2017 [45] 66/m A. naeslundii Ertapenem for 4 weeks Percutaneous drainage of 
the abscess
Culture
Taiwan, 2001 [46] 6/m NR Penicillin then Clindamycin 
for 4 month
The right kidney and 
liver were adequately 
debrided
HE
Taiwan, 2005 [47] 71/m NR Penicillin G and V for 
3 month
NR HE
Taiwan, 2005 [47] 73/f NR Penicillin V for 3 month Segmentectomy HE
Taiwan, 2010 [48] 78/m A. odontolyticus Ceftriaxone, ampicillin–sul-
bactam and Amoxicillin 
for 6 weeks
CT-guided pigtail catheter 
insertion for drainage of 
the abscess
Culture, PCR
Taiwan, 2013 [49] 49/f A. israelii Benzyl penicillin and 
imipenem/cilastatin
An exploratory laparotomy 
and right lobectomy of 
the liver
HE
Taiwan,2009 [1] 37/m NR Penicillin for 3 months Resected spleen and liver 
nodules
HE
Turkey 2010 [50] 40/M NR Penicillin G for 2 month Surgical debridement and 
drainage was performed
HE
Turkey, 2002 [51] 41/F NR Penicillin G The mass was excised HE
Turkey, 2003 [52] 11/F NR Penicillin G for 1 month 
then Amoxicillin
NR Culture
Turkey, 2006 [53] 40/F NR Penicillin G, a 6-month 
amoxicillin
Thoracentesis and thorax 
tube was inserted 
upon the diagnosis of 
empyema
HE with negative culture
Turkey, 2007 [54] 5/F NR Penicillin G for the next 
6 months
NR HE
Turkey, 2007 [55] 46/m NR Penicillin G 3 month NR HE
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other hand, most of the patients (80%) had complications 
with the most frequent one being previous history of 
abdominal surgery (32%), foreign bodies in the abdomi-
nopelvic region (20%) (Intrauterine Contraceptive Device 
(IUD) in nine cases, stenting of the bile duct in two cases, 
pancreatic duct stenting, and accidentally ingested fish 
bone) and diabetes (17%) (Fig. 2).
Only 14 studies (22%) performed the species-level 
identification and A. israelii was the most common path-
ogen isolated from patients with eight reports, followed 
Table 1 (continued)
Country, year of 
publication and 
references
Sex/age Species Treatment Surgery or puncture 
drainage
Diagnosis
UK, 2009 [2] 52/M NR Teicoplanin, meropenem 
and metronidazole then 
six month amoxicillin
The hepatic abscess 
was aspirated and a 
drain, anterior colonic 
resection with primary 
anastamosis
Culture
UK, 2011 [56] 50/M NR Died before treatment NR Autopsy (The patient died)
UK, 2012 [57] 38/f A. israelii co-amoxiclav for 7 month Ultrasound-guided drain-
age of the liver abscess 
was required 5 months 




USA, 2000 [58] 40/f A. israelii Penicillin NR Gram and immunofluores-
cent staining
USA, 2001 [59] 16/m NR Penicillin 6 months oral 
doxycycline
Laparotomy and open 
biopsy
HE and culture
USA, 2002 [60] 59/M A. turicensis Piperacillin-tazobactam, 
Doxycycline orally for 
4 months
The abscess was aspirated 
and a drain was placed
Culture and PCR
USA, 2002 [61] 34/m NR Ciprofloxacin was contin-
ued for 6 weeks and Clin-
damycin for 3 months
The abscess was incised 
and drained
Gram staining
USA, 2005 [62] 84/f NR Penicillin NR Gram staining
USA, 2006 [5] 46/m A. israelii Penicillin Percutaneous aspiration 
of the two largest liver 
collections
Culture
USA, 2006 [5] 59/m A. israelii Penicillin Drainage Culture
USA, 2010 [10] 75/F NR Clindamycin for 6 months Laparotomy with biopsy of 
the liver
HE
USA, 2011 [63] 65/m NR Doxycycline for 6 month Resection of segment 5 
and 6 of the liver without 
any complications
Culture
USA, 2013 [64] 48/m A. naeslundii Amoxicillin-clavulanate for 
six month
Drainage catheter Culture
USA, 2016 [65] 43/M NR Penicillin G for one month 
then Amoxicillin for one 
year
Right hemi hepatectomy HE
USA, 2016 [66] 73/m NR Penicillin G Incision and drainage of an 
abscess
HE
USA, 2017 [67] 70/m NR Penicillin NR HE
USA, 2017 [68] 80/m NR Penicillin G for 4 weeks 
then transitioned to 
oral penicillin for about 
9 months
Aspiration of the fluid 
collection
HE and culture
USA, 2019 [69] 35/F NR Ampicillin /sulbactam for 
6 weeks
NR HE
USA, 2020 [70] 59/M A. naeslundii or A. viscosus Amoxicillin for 6 month Extraction of a hepatic 
segment II
PCR
M Male, F Female, HE histopathological examination, NR not reported, PCR polymerase chain reaction
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by A. naeslundii with two reports and A. cardiffensis, A. 
odontolyticus, and A. turicensis each with one case. Nota-
bly, in one study, the causative pathogen was reported to 
be of either A. naeslundii or A. viscosus species consid-
ering the fact that there was no difference between the 
two in Polymerase Chain Reaction (PCR) with 16 s rRNA 
primer set (Table  1). Finally, the infection was mixed 
with other organisms in 17 cases (26%) with the available 
information in Additional file 1: Table S4.
Clinical manifestations
The most common manifestations were abdominal pain 
(66%), fever (62%) and weight loss (48%). Other clinical 
manifestations of patients are displayed in Fig.  3. Initial 
laboratory observations revealed leukocytosis, anemia, 
and elevated alkaline phosphatase (ALP) in 43 (67%), 35 
(55%), and 29 (45%) patients, respectively (Fig. 3). Onset 
was chronic or subacute with an extended duration of 
symptoms (mean ± SD = 3.1 ± 3.9  month) such that the 
shortest duration was one month and the longest 2 years. 
Fig. 2 The most common complications in patients with hepatic 
actinomycosis
Fig. 3 Characteristic of patients with hepatic actinomycosis. RUQT Right upper quadrant tenderness, ALP alkaline phosphatase, AST aspartate 
transaminase, ALT alanine transaminase, CRP C-reactive protein, ESR erythrocyte sedimentation rate, CA carbohydrate antigen, AFP alpha-fetoprotein
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A more acute presentation (< 2  week) was reported 
in 15 (26%) cases (in six patients, the duration of onset 
of symptoms was not reported; therefore, they were 
excluded from the final analysis).
In 18 patients (28%), the infection extended to one or 
more surrounding organs or tissues including diaphragm, 
abdominal wall, lungs, transverse colon, stomach with 
extension to the gastric muscularis propria, thorax, and 
inferior vena cava. For six other patients, it was assumed 
that hepatic abscess caused Thrombotic Thrombocy-
topenic Purpura (TTP), acute cardiac tamponade (in 
two cases), hepatic artery invasion with encasement of 
the portal vein and celiac and liver hilum adenopathies, 
hepatic vein and IVC thromboses, and finally right pul-
monary empyema (Additional file 1: Table S1).
Diagnosis
The diagnosis was confirmed by histopathologic exami-
nation of different specimens in 43 of 64 (67%) instances: 
liver puncture biopsy in 14 cases, liver lobe resection in 
13 cases, laparoscopic or surgical tissue in 9 cases, and 
autopsy in one case. In six other patients, histopatho-
logic examination of samples other than liver, includ-
ing resected appendix, pipelle endometrial biopsy, 
pelvic tumor, adnexae, thoracoscopic lung biopsy, right 
salpingo-oophorectomy and bilateral salpingo-oopho-
rectomy, small bowel resection, and appendectomy led to 
actinomycosis detection. Sulfur granules were reported 
from 36 (56%) patients. Although liver puncture biopsy 
was performed for 10 patients, it did not lead to the diag-
nosis of actinomycosis and in one patient, needle aspi-
ration could not be performed, because the liver lesions 
suspicious for hydatid cyst were localized subcapsularly 
(Additional file 1: Table S1 presents all the findings from 
histopathological examinations).
In five (7.9%) other patients, the information obtained 
from culture and histopathologic examination led to the 
diagnosis of infection. Furthermore, culture alone diag-
nosed actinomycosis in seven patients (11%). Notably, 
culture was not used to diagnose infection in 24 (37%) 
patients and out of 40 patients for whom this method 
of diagnosis was used, only 18 (45%) cases came posi-
tive. Aspirate obtained from the hepatic abscess and 
tissue specimens resulted in positive culture for 12 and 
three patients, respectively. Blood, material spontane-
ously drained through a fistula between liver and skin, 
and pericardial fluid cultures also led to the diagnosis of 
actinomycosis in three other cases. The duration of posi-
tive culture was reported in only three patients, which 
was eight and 10 days for the aspirate obtained from the 
hepatic abscess of two patients and four days for pericar-
dial fluid. Blood culture was reported in 13 instances and 
found positive in the detection of actinomycosis in only 
two (15%) cases.
Polymerase Chain Reaction (PCR) was used to confirm 
the diagnosis of infection in only one (1.6%) patient. In 
five (7.9%) other cases, culture system (API system in two 
cases and VITEK II system in two other patients) could 
not confirm the bacteria’s species and identification of 
the level of phenotypic species was impossible. Therefore, 
genomic identification was performed by 16S ribosomal 
RNA gene sequencing analysis. Finally, in three instances 
(4.6%) (Fig. 4), gram staining of transthoracic needle aspi-
ration, hepatic lesion, and pleural fluid aspiration without 
the use of any other diagnostic method led to the identifi-
cation of actinomycosis in the patients (Additional file 1: 
Table S1).
Fig. 4 Different methods that led to the diagnosis of hepatic actinomycosis. HE Histopathologic examination, PCR polymerase chain reaction
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Medical imaging modalities of Computed Tomog-
raphy (CT), Magnetic Resonance Imaging (MRI), and 
ultrasound did not give a definitive diagnosis for any of 
the patients. Among the ultrasound, MRI, and CT infor-
mation for the patients, the most frequent finding was a 
single abscess or mass (57%). The right lobe (52%) was 
the most frequently affected, followed by the left lobe 
(26%) and both lobes (21%). The imaging characteris-
tics of HA were mainly mass-like and nodular (70% of 
cases), abscess-like (67%), low density (50%) and solid 
tumor-like (32%). In addition, a few (26%) hypodense 
cystic cases were observed. The available information on 
medical imaging modalities is shown in Additional file 1: 
Table S2.
Information from the patients’ clinical signs, imaging, 
and liver puncture biopsy led to the suspicion of liver 
malignant tumor or liver metastasis, hepatic inflam-
matory pseudotumor, and pyogenic liver abscesses in 
32 (50%), seven (11%) and 20 (31%) cases, respectively 
(Fig. 3). All the findings that gave the diagnosis of HA in 
patients are fully provided in Tables S1 and S2.
Treatment
From the data available in the literature, in a total of 64 
cases, surgery or puncture drainage + anti-infection, 
liver lobe resection + anti-infection, anti-infection alone, 
and liver lobe resection alone were used for 30 (46%), 14 
(21%), 18 (28%), and one patient, respectively. One of the 
patients died before starting the treatment and in another 
case, no information was reported about the type of drug 
the patient was taking. Therefore, they were excluded 
from the final analysis. Antibiotics including penicillin 
(32 patients, 51%), Amoxicillin (17 patients, 27%), Dox-
ycycline and ampicillin (six patients, 9%) were the most 
frequently used drugs for the treatment of HA in patients 
(Fig.  3). Duration of treatment was state in 45 cases 
and the mean duration of treatment was 5.5  months 
(mean ± SD = 5.5 ± 3.8 months ranging from one week to 
24 months). As mentioned, with regard to the clinical and 
laboratory symptoms, pyogenic liver abscesses were sus-
pected in a number of patients. For this reason, the use of 
empirical therapies to cover a wide range of bacteria was 
prescribed for them. However, in almost all of the cases, 
no improvement was achieved. Additional file 1: Table S3 
covers these empirical treatments and their implications.
Discussion
HA is a very rare abdominal actinomycosis type and 
generally occurs after abdominal infection [36, 38]. 
Our results showed any age group could be infected, 
although patients over the age of 55 seemed to be more 
prone to this infection. Also, the rate of infection was 
higher in men between 50 and 70  years as the most 
susceptible group. The reason for the male predomi-
nance was uncertain, but all forms of actinomycosis 
were recognized in observations [61]. Previous stud-
ies also reported that HA was usually seen in males, 
but the most common age range for the infection in 
these studies was 30–50  years [47, 71]. These studies 
were conducted in more distant years than the present 
research (1990–2005). Therefore, it seems that in recent 
years, the average age of men for HA has increased. On 
the other hand, females have been more often affected 
probably due to a long-term use of the IUD and endo-
metrial colonization with A. israelii [51, 72]. Our analy-
sis showed that although the diagnosis was often made 
late and as a result, a delay occurred in initiating the 
therapy, the outcome was totally acceptable and the 
mortality rate was 1.5%. (1/64). In a recent study that 
was conducted with HA cases from 1966 to 2002, the 
overall mortality rate was 8.8% (5/57) [61]. Therefore, 
it seems that due to the good response of HA to treat-
ment, there has been no significant change in the mor-
tality rate in recent years.
Our finding showed that most of the patients experi-
enced complications, the most frequent cases of which 
were a previous history of abdominal surgery, pelvic 
colonization due to the use of an IUD, and oral diseases 
or dental surgery. HA often occurs through the por-
tal vein after the mechanical disruption of the intestinal 
normal physical barriers in case of surgery intervention 
and mucosal trauma or via the hepatic artery during 
hematogenous spread from an oral source [27, 73, 74]. 
Thus, patients with poor oral hygiene, history of IUD, or 
intra-abdominal surgery should be evaluated further for 
HA. Although for preventing HA, we do not have spe-
cific measures yet, keeping good personal dental hygiene 
and, specifically, removing dental plaque may be effec-
tive in reducing the density. However, effectiveness of 
such measures in reducing the probability of incidence 
of colonization and low-grade periodontal infection with 
Actinomyces species is not proved [75]. In 13 cases, no 
disorders were reported that could predispose a patient 
to HA. Therefore, the liver can be involved without dis-
rupting the tissue barriers [71]. A recent study reported 
that the infiltrative nature and rapid progression of actin-
omycosis along with its potential for invading the normal 
anatomic barriers was probably due to the proteolytic 
enzymes of Actinomyces species [50]. These microorgan-
isms, by using proteolytic enzymes, can propagate from 
the liver towards diaphragm and lungs or penetrate the 
pleural space through lymph vessels or pleuro-peritoneal 
communications on the diaphragm [42, 76]. Thus, Actin-
omyces species secrete proteolytic enzymes, penetrate 
even normal anatomic barriers, and infiltrate the dia-
phragm; they are complicated by pleural and lung lesions, 
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make cutaneous fistula, and extend to the abdominal and 
pelvic organs [31].
The clinical signs of HA are usually nonspecific and 
similar to other infections. However, abdominal pain, 
fever, and weight loss are the most reported signs among 
the patients. Anemia and leukocytosis are also other 
symptoms reported in more than half of the patients. 
Unlike pyogenic abscess in which 63% of patients have 
elevated AST levels and 70% of patients have elevated 
ALT levels, based on the findings of this study, less than 
one-third of the patients have elevated AST and ALT 
levels with HA [47, 77]. Increased levels of CA19-9 and 
CA-125 were reported in five cases. Our finding showed 
that in patients with HA, tumor marker levels were lower 
(50–278  U/ml) than those with malignant conditions 
and at levels greater than 1000 U/ml, the marker’s posi-
tive predictive value approached 100% [30]. This might 
be due to the enhanced production of CA 19–9 from 
biliary epithelial cells, which is prevalent in the course 
of benign diseases of the biliary tract, and/or the reduc-
tion in hepatobiliary clearance because cholestasis may 
have led to the increased levels of CA 19–9 in the blood 
[30]. However, CA19-9 has inadequate sensitivity and 
specificity to be used as a marker for differentiating HA 
from liver tumors and appropriate consideration of this 
marker might turn out useful in the difficult diagnosis. A 
study has reported that high mobility group box chromo-
somal protein 1 (HMGB1) may have a potent biological 
effect on the pathogenesis of HA as a novel cytokine and 
may be a useful marker in the differential diagnosis of 
HA [22]. Thus, this marker deserves higher attention in 
future studies. Clinical manifestation and laboratory tests 
are non-specific in patients with HA and correct diagno-
sis of infection is the most difficult step in controlling this 
infection.
In none of the cases, the imaging modalities result in a 
definitive diagnosis of infection in the patients. As men-
tioned, on CT, HA is mainly seen as a single or multiple 
low-density shadows, which may be accompanied by 
enhancement. The border is often unclear in this type of 
images. Thus, it is very difficult to distinguish HA from 
ordinary bacterial abscesses, inflammatory masses, soli-
tary metastatic lesions, and primary liver masses on CT 
or MRI [32, 63]. In this context, in eight cases (12%), mis-
diagnosis based on imaging information led to surgery in 
patients and perhaps if the HA had been correctly diag-
nosed in these patients, extensive surgery would not have 
been necessary at all [12, 20–23, 50, 53, 63]. In another 
patient, lesions in liver were not detected by the CT scan 
either, because they were only approximately 0.5  cm in 
size, which was beyond the limitations of CT cutting by 
1  cm [1]. On the other hand, two studies reported that 
the use of Contrast Enhanced Ultrasonography (CEUS) 
might help demonstrate the inflammatory substrate of 
the lesion and could be very useful for visualizing the 
lesions and evaluating central liquefaction during the 
arterial phase as well as the status of the disease. Thus, 
this technique should be more investigated in future 
patients [32, 41].
Due to the limitations that exist for imaging modali-
ties, the final diagnosis is made on patohystology, which 
is the gold standard to confirm or exclude the diagno-
sis of HA [42]. Histopathologic examination of different 
samples confirmed the diagnosis of HA in 67% of the 
patients. On the other hand, histopathologic examina-
tion of samples from liver puncture biopsy and liver lobe 
resection did not help diagnose actinomycosis in 10 and 
one patient, respectively. Recent studies have reported 
that, without absolute bacterial identification, the most 
helpful diagnostic finding is the detection of sulfur gran-
ules, also confirmed in the present study with 56% of the 
patients [38, 78]. However, when only small quantities of 
tissues are available, sulfur granules can be easily missing 
and only inflammation or fibrosis may be identified [8]. 
Therefore, per-cutaneous biopsy diagnosis is not always 
fruitful and the organism cannot be seen, because the 
typical sulfur granules are present in the part of the lesion 
that the biopsy does not reach. Hence, it is recommended 
that an exploratory laparotomy be adopted for exact 
diagnosis and treatment [21]. On Hematoxylin and Eosin 
(H&E) stains, the bacteria are clumped by the radiating 
fringe of club-like organisms in the sulfur granules and 
surrounded by neutrophils and lymphocytes. Grocott-
Gomori methenamine silver staining is used to identify 
branching organisms that characterize the presence of 
actinomycosis. Multinucleated giant cells or granulomas 
may be seen in a number of cases. However, these mor-
phological results are not specific to actinomycosis, since 
other microorganisms like Nocardia species and certain 
fungal or parasitic infections can lead to similar mor-
phological outcomes [1, 34]. Therefore, histopathologic 
examination of different samples also has limitations for 
diagnosis and, for some patients, we need to use other 
ways such as culture and molecular methods for defini-
tive diagnosis of infection.
Our analysis showed that culture was not used to diag-
nose HA in 37% of the patients and positive results were 
reported in only 18 patients. The failure rate of culture 
is quite high often due to growth suppression caused by 
prior antibiotic therapy, improper specimen gathering 
and transportation techniques, lack of the proper media, 
and inadequate culture conditions [8, 70]. On the other 
hand, while a recent study has reported that positive 
peripheral blood culture is one of the diagnostic meth-
ods for actinomycosis in patients, our results indicated 
that only two patients had a positive blood culture [37, 
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61]. Thus, it is difficult to culture Actinomyces while, iso-
lating bacteria from clinical specimens may be necessary 
to separate nocardiosis or botryomycosis from actino-
mycosis, diseases that are often morphologically difficult 
to distinguish. Therefore, direct inoculation of aspirated 
pus or liver biopsy material into both aerobic and anaero-
bic blood culture samples may elevate culture sensitivity 
[79].
The use of molecular methods can be helpful in diag-
nosing HA, although for only six cases (9%) PCR was 
used according to the findings of the present study. In 
one patient, ultrasound guided liver biopsy and diag-
nostic laparoscopy with excisional biopsy of a lesion did 
not make an HA diagnosis. Due to the positive Quantif-
eron-TB test, the liver lesions were thought secondary 
to disseminated reactivated tuberculosis and the patient 
underwent RIPE therapy. In this patient, who had a very 
complex condition, the use of PCR resulted in the cor-
rect diagnosis of Actinomyces DNA and hence, the use 
of appropriate therapies [70]. Accordingly, it can be con-
cluded that each method of diagnosing HA has its limita-
tions and many patients undergo hepatectomy and other 
extensive surgery due to the difficulty in detecting Actino-
myces and distinguishing between Actinomyces abscesses 
and malignant tumors. Recently, new molecular genetic 
methods such as PCR for 16S rRNA sequencing and fluo-
rescence in  situ hybridization have been developed to 
achieve faster and more accurate identification in refer-
ence or research laboratories [32, 80]. Such methods are 
highly recommended when there are many challenges to 
diagnosing HA in the patient.
With correct diagnosis of this infection in patients, the 
response for treatment was usually good and our find-
ing showed only one death from HA [56]. On the other 
hand, HA could easily extend transdiaphragmatically to 
the pericardium and provoke serious illness. Thus, early 
definitive diagnosis and appropriate antibiotics therapy 
are critically important [9]. In this context, in one patient, 
the failure in the first therapy led to transdiaphragmatic 
spread of HA and its extension into the pericardium 
caused acute cardiac tamponade [9]. It is noteworthy that 
Actinomyces spp. are usually highly susceptible to beta-
lactams, especially penicillin G or Amoxicillin. Amoxi-
cillin offers high potency in diffusing into inflamed liver 
tissue and is thus the preferable compound for treating 
HA [25].
Surgery is another treatment strategy used for 
patients with HA. There have been many controver-
sies in previous studies about how to use surgery. Our 
findings showed that 28% of the patients were treated 
with anti-infection alone and only one case was treated 
with liver lobe resection alone. One study reported 
that the outcome of hepatectomy was excellent since 
no recurrence was observed [27]. Another case also 
reported that initial treatment with benzyl penicillin 
and imipenem/cilastatin was ineffective and an explor-
atory laparotomy and right lobectomy of the liver were 
performed [49]. Hence, surgery needs to be adopted 
for the cases in which percutaneous drainage is not 
possible, for larger lesions in which there is a greater 
amount of necrotic tissue, and when symptoms are not 
improved or are aggravated after treatment [28, 36]. On 
the other hand, as mentioned, in some cases, extended 
resection was unnecessarily performed. Hence, using 
preoperative empirical antibiotics and excluding 
malignant tumors during surgery via frozen biopsy 
are recommended. Applying this strategy can ensure 
a reduction in the extent of surgery and postoperative 
complications in patients with actinomycosis indistin-
guishable from malignant tumor before surgery [38]. 
Finally, it should be noted that because of the tendency 
of the disease to recur, the antibiotic treatment should 
incorporate high doses and have a prolonged duration. 
A long-term follow-up is also required to monitor the 
treatment response and detect any recurrence earlier. 
The duration of treatment should be individualized 
based on a number of factors including disease loca-
tion, severity, and changes in follow-up imaging.
Limitation
The present study included only PubMed/Medline stud-
ies available in English language, which contained an 
abstract, hence reducing the number of relevant publi-
cations. It was not possible to discuss the bias, risks, or 
individual limitations of the studies, since they were not 
reported.
Conclusion
HA is a difficult disease to diagnose due to its rarity, non-
specific symptoms, failure of identifying the microorgan-
ism, and imitation of more common conditions. In many 
patients, this infection is confused with other diseases, 
which may lead to extensive surgery. Therefore, it is rec-
ommended that HA be diagnosed correctly before decid-
ing on surgery by using a variety of diagnostic methods 
considering the fact that, in many patients, infection can 
be controlled using only antibiotics. Finally, due to the 
tendency of the disease to recur, the antibiotic treatment 
must incorporate high doses and have a prolonged dura-
tion. A long-term follow-up is also necessary to monitor 
the treatment response and detect any recurrence early. 
The duration of treatment should be individualized based 
on disease location, severity, and changes in follow-up 
imaging.
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